Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS).

作者: J Barrett , V Jenkins , V Farewell , U Menon , I Jacobs

DOI: 10.1111/1471-0528.12870

关键词:

摘要: Objective To examine the psychological sequelae associated with abnormal screening in United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Design Prospective, longitudinal randomised control trial. Setting Sixteen UKCTOCS centres. Sample Women aged 50–70 years to annual multimodal screening, ultrasound or groups. Methods Two groups were followed for 7 years: (1) a random sample (n = 1339), taken from all three study groups; and (2) an events (n = 22 035) women screens resulting need repeat testing either low higher level intensity. Main outcome measures Patient-reported measures anxiety (scores ranging 20 80) morbidity. Results In mean difference between scores after those following was 0.4 (95% CI −0.46, 1.27), it 0.37 0.23, 0.51). The risk morbidity only increased event requiring (OR 1.28; 95% CI 1.18, 1.39). ovarian cancer at both 6 weeks (OR 16.2; 9.19, 28.54) 6 months (OR 3.32; 1.91, 5.77) surgery. Conclusions Screening does not appear raise but is elevated by more intense screens, surgical treatment cancer.

参考文章(16)
L Fallowfield, , A Fleissig, J Barrett, U Menon, I Jacobs, J Kilkerr, V Farewell, Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening British Journal of Cancer. ,vol. 103, pp. 454- 461 ,(2010) , 10.1038/SJ.BJC.6605809
Ruth E Collins, Laureen M Lopez, Theresa M Marteau, Emotional impact of screening: a systematic review and meta-analysis. BMC Public Health. ,vol. 11, pp. 603- 603 ,(2011) , 10.1186/1471-2458-11-603
James J. Gross, Laura L. Carstensen, Monisha Pasupathi, Jeanne Tsai, Carina Götestam Skorpen, Angie Y. C. Hsu, Emotion and aging: experience, expression, and control. Psychology and Aging. ,vol. 12, pp. 590- 599 ,(1997) , 10.1037/0882-7974.12.4.590
Clare J. Reade, John J. Riva, Jason W. Busse, Charlie H. Goldsmith, Laurie Elit, Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis. Gynecologic Oncology. ,vol. 130, pp. 674- 681 ,(2013) , 10.1016/J.YGYNO.2013.06.029
K. L. Taylor, R. Shelby, E. Gelmann, C. McGuire, Quality of Life and Trial Adherence Among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Journal of the National Cancer Institute. ,vol. 96, pp. 1083- 1094 ,(2004) , 10.1093/JNCI/DJH194
Anne Fleissig, Lesley J. Fallowfield, Carolyn I. Langridge, Leigh Johnson, Robert G. Newcombe, J. Michael Dixon, Mark Kissin, Robert E. Mansel, Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer Breast Cancer Research and Treatment. ,vol. 95, pp. 279- 293 ,(2006) , 10.1007/S10549-005-9025-7
Kate E. Brain, Kate J. Lifford, Lindsay Fraser, Adam N. Rosenthal, Mark T. Rogers, Deborah Lancastle, Ceri Phelps, Eila K. Watson, Alison Clements, Usha Menon, Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm Gynecologic Oncology. ,vol. 127, pp. 556- 563 ,(2012) , 10.1016/J.YGYNO.2012.08.034
Kate J. Lifford, Lindsay Fraser, Adam N. Rosenthal, Mark T. Rogers, Deborah Lancastle, Ceri Phelps, Eila K. Watson, Alison Clements, Rachel Iredale, Ian Jacobs, Usha Menon, Kate E. Brain, Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS) Gynecologic Oncology. ,vol. 124, pp. 158- 163 ,(2012) , 10.1016/J.YGYNO.2011.09.015
Usha Menon, Michelle Griffin, Aleksandra Gentry-Maharaj, Ovarian cancer screening—Current status, future directions Gynecologic Oncology. ,vol. 132, pp. 490- 495 ,(2014) , 10.1016/J.YGYNO.2013.11.030
U. Menon, A. Gentry-Maharaj, A. Ryan, A. Sharma, M. Burnell, R. Hallett, S. Lewis, A. Lopez, K. Godfrey, D. Oram, J. Herod, K. Williamson, M. Seif, I. Scott, T. Mould, R. Woolas, J. Murdoch, S. Dobbs, N. Amso, S. Leeson, D. Cruickshank, A. McGuire, S. Campbell, L. Fallowfield, S. Skates, M. Parmar, I. Jacobs, Recruitment to multicentre trials — lessons from UKCTOCS: descriptive study BMJ. ,vol. 337, pp. 1283- 1286 ,(2008) , 10.1136/BMJ.A2079